Advantages of FIT as CRC screening method discussed

October 25, 2016

(HealthDay)—Fecal immunochemical testing (FIT) has advantages as a colorectal cancer (CRC) screening method, and should be a component of a screening program, according to an Ideas and Opinions piece published online Oct. 25 in the Annals of Internal Medicine.

In light of recent findings questioning the effectiveness of colonoscopy, David S. Weinberg, M.D., from the Fox Chase Cancer Center in Philadelphia, and colleagues discussed CRC screening methods.

The researchers note that a U.S. Multi-Society Task Force recently released an examination of the evidence relating to use of FIT for CRC screening, emphasizing the advantages of FIT over guaiac-based fecal occult blood testing. Advantages include higher sensitivity while maintaining similar specificity; more consistent detection of advanced adenomas; and patient preference for FIT. Recent studies show that FIT-based screening yields a reduction in CRC incidence similar to that of colonoscopy when adherence to serial completion is high, and patients are more likely to choose FIT over colonoscopy; consequently, more cancers (but fewer advanced adenomas) could be detected with FIT screening. Practical concerns surround implementation of annual FIT screening; for example, a large-scale FIT screening would require efficient tracking mechanisms.

"For primary care and other clinicians who provide CRC screening services, this authoritative consensus statement offers strong evidence for FIT as an excellent alternative for CRC prevention," the authors write.

Explore further: Study: Colonoscopy after 75 may not be worth it

More information: Full Text (subscription or payment may be required)

Related Stories

Study: Colonoscopy after 75 may not be worth it

September 26, 2016
(HealthDay)—A colonoscopy can find and remove cancerous growths in the colon, but it may not provide much cancer prevention benefit after the age of 75, a new study suggests.

Support for fecal testing in familial colorectal cancer screening

October 29, 2014
Fecal immunochemical tests (FIT) may be as effective as colonoscopies when it comes to detecting colorectal cancer among first-degree relatives of patients with colorectal cancer, according to a new study in Gastroenterology, ...

Hybrid screening strategy emerges for colorectal cancer

August 27, 2013
A strategy that combines two effective colorectal cancer screening methods, fecal immunological test and colonoscopy, may improve prevention and detection of colorectal cancer and reduce costs, according to a new study in ...

Colonoscopy is indicated in unscreened elderly patients

June 3, 2014
(HealthDay)—Colorectal cancer (CRC) screening should be considered as a cost-effective strategy in unscreened patients older than 75 years, according to research published in the June 3 issue of the Annals of Internal Medicine.

Cancers caught during screening colonoscopy are more survivable

July 13, 2015
Patients whose colorectal cancer (CRC) is detected during a screening colonoscopy are likely to survive longer than those who wait until they have symptoms before having the test, according to a study in the July issue of ...

Study finds stool test effective for detecting colon cancer

January 26, 2016
(HealthDay)—Tests for blood in the stool can consistently detect colon cancer when used on an annual basis, and they are effective even in the second, third and fourth years of screening, a new study says.

Recommended for you

Lab-grown 'mini tumours' could personalise cancer treatment

February 23, 2018
Testing cancer drugs on miniature replicas of a patient's tumour could help doctors tailor treatment, according to new research.

Study tracks evolutionary transition to destructive cancer

February 23, 2018
Evolution describes how all living forms cope with challenges in their environment, as they struggle to persevere against formidable odds. Mutation and selective pressure—cornerstones of Darwin's theory—are the means ...

Researchers use a molecular Trojan horse to deliver chemotherapeutic drug to cancer cells

February 23, 2018
A research team at the University of California, Riverside has discovered a way for chemotherapy drug paclitaxel to target migrating, or circulating, cancer cells, which are responsible for the development of tumor metastases.

An under-the-radar immune cell shows potential in fight against cancer

February 23, 2018
One of the rarest of immune cells, unknown to scientists a decade ago, might prove to be a potent weapon in stopping cancer from spreading in the body, according to new research from the University of British Columbia.

Putting black skin cancer to sleep—for good

February 22, 2018
An international research team has succeeded in stopping the growth of malignant melanoma by reactivating a protective mechanism that prevents tumor cells from dividing. The team used chemical agents to block the enzymes ...

Cancer risk associated with key epigenetic changes occurring through normal aging process

February 22, 2018
Some scientists have hypothesized that tumor-promoting changes in cells during cancer development—particularly an epigenetic change involving DNA methylation—arise from rogue cells escaping a natural cell deterioration ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.